Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma
Authors:
Open Access
- 30 July 2021
- journal article
- research article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 27, e932126-1-e932126-11
Abstract
Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma - Article abstract #932126Keywords
This publication has 25 references indexed in Scilit:
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- Quality of Life Among Long-Term Survivors of Head and Neck Cancer Treated by Intensity-Modulated RadiotherapyJAMA Otolaryngology–Head & Neck Surgery, 2014
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013
- Tobacco Smoking During Radiation Therapy for Head-and-Neck Cancer Is Associated With Unfavorable OutcomeInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell TherapyCancer Research, 2010
- A Gene Expression Model of Intrinsic Tumor Radiosensitivity: Prediction of Response and Prognosis After ChemoradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatmentBlood, 2009
- Head and neck cancerThe Lancet, 2008
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Long-term Quality of Life for Surgical and Nonsurgical Treatment of Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2005